COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics (“Forge”), a leading ... The Rejuva platform is in preclinical development and has not yet been evaluated by regulatory agencies for ...

HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and ...

Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn ...

ABCL575 is a novel, half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of ...

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...